ANDAs Must Include All Bioequivalence Data: FDA
By Sara Stefanini · January 20, 2009, 12:00 AM EST
The U.S. Food and Drug Administration issued a final rule Tuesday requiring pharmaceutical companies that apply to sell generic medications to provide data from all the bioequivalence studies they conduct on...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login